Compare ARK Innovation ETF (ARKK) vs DexCom, Inc. (DXCM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Innovation ETF vs DexCom, Inc. — how do they compare? ARK Innovation ETF trades at $81.84, while DexCom, Inc. trades at $89.2 (market cap $33.79B). The key difference: DexCom, Inc. is trading nearer its 52-week high, ARK Innovation ETF nearer its low. Which is the better fit depends on your goals.
| ARKK | DXCM | |
|---|---|---|
52-Week High | $92.50 | $89.53 |
52-Week Low | $63.52 | $54.84 |
Market Cap | — | $33.79B |
Sector | — | Health |
Enterprise Value | — | $33.24B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Innovation ETF
The fund will invest under normal circumstances primarily (at least 65% of its assets) in domestic and foreign equity securities of companies that are relevant to the fund’s investment theme of disruptive innovation. Its investments in foreign equity securities will be in both developed and emerging markets. The fund may invest in foreign securities listed on foreign exchanges as well as American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs). The fund is non-diversified.
Read more on ARKK →About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →
